Brain Disorders

Annovis Bio Achieves Major Alzheimer’s Trial Milestone

Annovis Bio successfully achieved full enrollment for its pivotal Phase 3 clinical trial of buntanetap, a promising oral drug for early Alzheimer's disease. Exceeding original projections...